DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer.
Document Type
Journal Article
Publication Date
4-26-2018
Journal
Cancer Letters
Volume
428
Inclusive Pages
104-116
DOI
10.1016/j.canlet.2018.04.029
APA Citation
Meng, Y., Chen, C., Yung, M., Sun, W., Sun, J., Li, Z., Li, J., Li, Z., Zhou, W., Liu, S., Cheung, A., Ngan, H., Braisted, J., Kai, Y., Peng, W., Tzatsos, A., Li, Y., Dai, Z., Zheng, W., Chan, D., & Zhu, W. (2018). DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer.. Cancer Letters, 428 (). http://dx.doi.org/10.1016/j.canlet.2018.04.029
Peer Reviewed
1
